on May 20, 2004
Published online before print May 20, 2004, doi: 10.1161/01.ATV.0000133193.11078.c0
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on February 20, 2004
Accepted on March 15, 2004
Enhanced P2X7 Activity in Human Fibroblasts From Diabetic Patients. A Possible Pathogenetic Mechanism for Vascular Damage in Diabetes
Anna Solini ;
From the Department of Internal Medicine (A.S.), University of Pisa, Italy; the Department of Experimental and Diagnostic Medicine (P.C., A.M., E.A., R.R., O.R.B., F.D.), University of Ferrara, Italy; and the Interdisciplinary Center for the Study of Inflammation (F.D.), University of Ferrara, Italy.
* To whom correspondence should be addressed. E-mail: fdv{at}unife.it.
Objective--We have investigated expression and function of the P2X7 receptor in fibroblasts from healthy subjects and patients with type 2 diabetes.
Methods and Results--Fibroblasts were isolated from skin biopsies. P2X7 receptor expression in both cell populations was measured by functional assays, RT-PCR, fluorescence-activated cell sorter, and immunoblotting. We found that fibroblasts from diabetic subjects are characterized by enhanced P2X7-mediated responses as indicated by increased shape changes, microvesiculation, enhanced fibronectin and interleukin 6 secretion, and accelerated apoptosis. These responses were blocked by preincubation with the P2X blockers KN-62, oxidized ATP, or pyridoxal phosphate-6-azo(benzene-2,4-disulfonic acid). Furthermore, we also found a higher level of spontaneous fibronectin secretion and of apoptosis in fibroblasts from diabetic compared with healthy subjects. Both higher basal level of fibronectin secretion and spontaneous rate of apoptosis were likely attributable to the increased pericellular concentration of ATP because fibroblasts from diabetic subjects released 3x as much ATP into the supernatants compared with fibroblasts from healthy subjects.
Conclusions--We conclude that fibroblasts from type 2 diabetes patients are characterized by a hyperactive purinergic loop based either on a higher level of ATP release or on increased P2X7 reactivity.
Key words: P2 receptors • fibroblasts • atherosclerosis • cytokines • diabetes • apoptosis
This article has been cited by other articles:
 |
|
 |
|
  A. Lo Monaco, S. Gulinelli, G. Castellino, A. Solini, D. Ferrari, R. La Corte, F. Trotta, and F. Di Virgilio Increased sensitivity to extracellular ATP of fibroblasts from patients affected by systemic sclerosis Ann Rheum Dis, August 1, 2007; 66(8): 1124 - 1125. [Full Text] [PDF]
|
|
|
|
 |
|
 P. Pellegatti, S. Falzoni, P. Pinton, R. Rizzuto, and F. Di Virgilio A Novel Recombinant Plasma Membrane-targeted Luciferase Reveals a New Pathway for ATP Secretion Mol. Biol. Cell, August 1, 2005; 16(8): 3659 - 3665. [Abstract] [Full Text] [PDF]
|
|